Eid D

Analysis Group, Inc., Boston, MA, USA.

2 papers

ArticleKetamine

Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression.

Clemens K, Rive B, Joshi K +7

Europe PMC2025
ArticleKetamine

Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression.

Clemens K, Teeple A, Rive B +7

Europe PMC2025